-
1
-
-
33645454744
-
Schizophrenia and bipolar disorder: differences and overlaps
-
PID: 16612197
-
Maier W, Zobel A, Wagner M (2006) Schizophrenia and bipolar disorder: differences and overlaps. Curr Opin Psychiatry 19(2):165–170
-
(2006)
Curr Opin Psychiatry
, vol.19
, Issue.2
, pp. 165-170
-
-
Maier, W.1
Zobel, A.2
Wagner, M.3
-
2
-
-
35848939420
-
Increased levels of glutamate in brains from patients with mood disorders
-
COI: 1:CAS:528:DC%2BD2sXht1ymu7nP, PID: 17574216
-
Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62(11):1310–1316
-
(2007)
Biol Psychiatry
, vol.62
, Issue.11
, pp. 1310-1316
-
-
Hashimoto, K.1
Sawa, A.2
Iyo, M.3
-
3
-
-
84881313914
-
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
-
PID: 23455590
-
Hashimoto K, Malchow B, Falkai P, Schmitt A (2013) Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci 263(5):367–377
-
(2013)
Eur Arch Psychiatry Clin Neurosci
, vol.263
, Issue.5
, pp. 367-377
-
-
Hashimoto, K.1
Malchow, B.2
Falkai, P.3
Schmitt, A.4
-
4
-
-
84906228003
-
Targeting of NMDA receptors in new treatments for schizophrenia
-
COI: 1:CAS:528:DC%2BC2cXhtl2nt7rL, PID: 24965576
-
Hashimoto K (2014) Targeting of NMDA receptors in new treatments for schizophrenia. Expert Opin Ther Targets 18(9):1049–1063
-
(2014)
Expert Opin Ther Targets
, vol.18
, Issue.9
, pp. 1049-1063
-
-
Hashimoto, K.1
-
5
-
-
0037977113
-
Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
-
COI: 1:CAS:528:DC%2BD3sXltlKht74%3D, PID: 12796220
-
Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M (2003) Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60(6):572–576
-
(2003)
Arch Gen Psychiatry
, vol.60
, Issue.6
, pp. 572-576
-
-
Hashimoto, K.1
Fukushima, T.2
Shimizu, E.3
Komatsu, N.4
Watanabe, H.5
Shinoda, N.6
Nakazato, M.7
Kumakiri, C.8
Okada, S.9
Hasegawa, H.10
Imai, K.11
Iyo, M.12
-
6
-
-
20444406392
-
Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels
-
COI: 1:CAS:528:DC%2BD2MXlt1GrsL0%3D, PID: 15953485
-
Yamada K, Ohnishi T, Hashimoto K, Ohba H, Iwayama-Shigeno Y, Toyoshima M, Okuno A, Takao H, Toyota T, Minabe Y, Nakamura K, Shimizu E, Itokawa M, Mori N, Iyo M, Yoshikawa T (2005) Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol Psychiatry 57(12):1493–1503
-
(2005)
Biol Psychiatry
, vol.57
, Issue.12
, pp. 1493-1503
-
-
Yamada, K.1
Ohnishi, T.2
Hashimoto, K.3
Ohba, H.4
Iwayama-Shigeno, Y.5
Toyoshima, M.6
Okuno, A.7
Takao, H.8
Toyota, T.9
Minabe, Y.10
Nakamura, K.11
Shimizu, E.12
Itokawa, M.13
Mori, N.14
Iyo, M.15
Yoshikawa, T.16
-
7
-
-
84903955216
-
Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients
-
PID: 25004141
-
Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T (2014) Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. Plos One 9(7):e101652
-
(2014)
Plos One
, vol.9
, Issue.7
, pp. e101652
-
-
Fukushima, T.1
Iizuka, H.2
Yokota, A.3
Suzuki, T.4
Ohno, C.5
Kono, Y.6
Nishikiori, M.7
Seki, A.8
Ichiba, H.9
Watanabe, Y.10
Hongo, S.11
Utsunomiya, M.12
Nakatani, M.13
Sadamoto, K.14
Yoshio, T.15
-
8
-
-
21244502642
-
Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
-
COI: 1:CAS:528:DC%2BD2MXlslymtbk%3D, PID: 15939521
-
Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindström LH, Iyo M (2005) Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 29(5):767–769
-
(2005)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.29
, Issue.5
, pp. 767-769
-
-
Hashimoto, K.1
Engberg, G.2
Shimizu, E.3
Nordin, C.4
Lindström, L.H.5
Iyo, M.6
-
9
-
-
33846640657
-
A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia
-
PID: 17156977
-
Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, Agam G (2007) A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr Res 90(1–3):41–51
-
(2007)
Schizophr Res
, vol.90
, Issue.1-3
, pp. 41-51
-
-
Bendikov, I.1
Nadri, C.2
Amar, S.3
Panizzutti, R.4
De Miranda, J.5
Wolosker, H.6
Agam, G.7
-
10
-
-
84904804929
-
Biological insights from 108 schizophrenia-associated genetic loci
-
The Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510):421–427
-
(2014)
Nature
, vol.511
, Issue.7510
, pp. 421-427
-
-
-
11
-
-
70949107578
-
Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study
-
COI: 1:CAS:528:DC%2BD1MXhsVWqu7rE, PID: 19823762
-
Habl G, Zink M, Petroianu G, Bauer M, Schneider-Axmann T, von Wilmsdorff M, Falkai P, Henn FA, Schmitt A (2009) Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study. J Neural Transm 116(12):1657–1665
-
(2009)
J Neural Transm
, vol.116
, Issue.12
, pp. 1657-1665
-
-
Habl, G.1
Zink, M.2
Petroianu, G.3
Bauer, M.4
Schneider-Axmann, T.5
von Wilmsdorff, M.6
Falkai, P.7
Henn, F.A.8
Schmitt, A.9
-
12
-
-
84920486612
-
Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls
-
PID: 25482684
-
Pålsson E, Jakobsson J, Södersten K, Fujita Y, Sellgren C, Ekman CJ, Ågren H, Hashimoto K, Landén M (2015) Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls. Eur Neuropsychopharmacol 25(1):133–140
-
(2015)
Eur Neuropsychopharmacol
, vol.25
, Issue.1
, pp. 133-140
-
-
Pålsson, E.1
Jakobsson, J.2
Södersten, K.3
Fujita, Y.4
Sellgren, C.5
Ekman, C.J.6
Ågren, H.7
Hashimoto, K.8
Landén, M.9
-
13
-
-
0028323167
-
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
-
COI: 1:CAS:528:DyaK2cXkslemtrY%3D, PID: 8122957
-
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51(3):199–214
-
(1994)
Arch Gen Psychiatry
, vol.51
, Issue.3
, pp. 199-214
-
-
Krystal, J.H.1
Karper, L.P.2
Seibyl, J.P.3
Freeman, G.K.4
Delaney, R.5
Bremner, J.D.6
Heninger, G.R.7
Bowers, M.B.8
Charney, D.S.9
-
14
-
-
0034851624
-
Effects of ketamine in normal and schizophrenic volunteers
-
COI: 1:CAS:528:DC%2BD3MXms12msLY%3D, PID: 11557159
-
Lahti AC, Weiler MA, Tamara M, Parwani A, Tamminga CA (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25(4):455–467
-
(2001)
Neuropsychopharmacology
, vol.25
, Issue.4
, pp. 455-467
-
-
Lahti, A.C.1
Weiler, M.A.2
Tamara, M.3
Parwani, A.4
Tamminga, C.A.5
-
15
-
-
77955891255
-
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
-
COI: 1:CAS:528:DC%2BC3cXhtV2rtrvK, PID: 20679587
-
Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67(8):793–802
-
(2010)
Arch Gen Psychiatry
, vol.67
, Issue.8
, pp. 793-802
-
-
Diazgranados, N.1
Ibrahim, L.2
Brutsche, N.E.3
Newberg, A.4
Kronstein, P.5
Khalife, S.6
Kammerer, W.A.7
Quezado, Z.8
Luckenbaugh, D.A.9
Salvadore, G.10
Machado-Vieira, R.11
Manji, H.K.12
Zarate, C.A.13
-
16
-
-
84926454370
-
d-serine plasma concentration is a potential biomarker of (R, S)-ketamine antidepressant response in subjects with treatment-resistant depression
-
COI: 1:CAS:528:DC%2BC2cXht1WksrrJ, PID: 25056852
-
Moaddel R, Luckenbaugh DA, Xie Y, Villaseñor A, Brutsche NE, Machado-Vieira R, Ramamoorthy A, Lorenzo MP, Garcia A, Bernier M, Torjman MC, Barbas C, Zarate CA Jr, Wainer IW (2015) d-serine plasma concentration is a potential biomarker of (R, S)-ketamine antidepressant response in subjects with treatment-resistant depression. Psychopharmacology 232(2):399–409
-
(2015)
Psychopharmacology
, vol.232
, Issue.2
, pp. 399-409
-
-
Moaddel, R.1
Luckenbaugh, D.A.2
Xie, Y.3
Villaseñor, A.4
Brutsche, N.E.5
Machado-Vieira, R.6
Ramamoorthy, A.7
Lorenzo, M.P.8
Garcia, A.9
Bernier, M.10
Torjman, M.C.11
Barbas, C.12
Zarate, C.A.13
Wainer, I.W.14
-
17
-
-
84919372680
-
Blood d-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine
-
COI: 1:CAS:528:DC%2BC2cXhsV2isbzE, PID: 25189793
-
Hashimoto K (2014) Blood d-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine. Psychopharmacology 231(20):4081–4082
-
(2014)
Psychopharmacology
, vol.231
, Issue.20
, pp. 4081-4082
-
-
Hashimoto, K.1
|